Top Markets
Coin of the day
Bristol-Myers Squibb Company Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

BMY
株式のランク #149
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and... Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.
株価
$59.43
時価総額
$121.03B
変化(1日)
0.83%
変化(1年)
0.90%
US
取引 Bristol-Myers Squibb Company (BMY)

カテゴリー

Bristol-Myers Squibb Company(BMY)の配当利回りの履歴
Bristol-Myers Squibb Company(銘柄コード: BMY)の配当利回り(TTM)は2024-12-31時点で4.24%です。
過去5年間の平均配当利回り: 3.90%
Bristol-Myers Squibb Company(BMY)の2000から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
2026 (TTM) 4.21% -8.48%
2025 4.60% 8.49%
2024 4.24% -5.15%
2023 4.47% 48.01%
2022 3.02% -4.73%
2021 3.17% 8.93%
2020 2.91% 18.78%
2019 2.45% -20.45%
2018 3.08% 20.31%
2017 2.56% -1.92%
2016 2.61% 20.83%
2015 2.16% -11.84%
2014 2.45% -7.20%
2013 2.64% -37.14%
2012 4.20% 11.70%
2011 3.76% -22.47%
2010 4.85% -2.61%
2009 4.98% -6.92%
2008 5.35% 26.18%
2007 4.24% -0.47%
2006 4.26% -12.53%
2005 4.87% 11.44%
2004 4.37% 11.48%
2003 3.92% -16.42%
2002 4.69% 117.13%
2001 2.16% 54.29%
2000 1.40% 0.00%
類似企業または競合他社の配当利回り(TTM)
企業 配当利回り
0.63%
US
1.64%
GB
2.15%
US
3.03%
US
3.05%
CH